Answers are grounded in this paper and cite their sources.
The editorial emphasizes the potential value of diagnostic and treatment algorithms for massive pulmonary embolism in district general hospitals, while calling for more robust historical comparisons and national evidence-based guidelines.
For nearly 40 years, physicians and surgeons have been observing and treating pulmonary thromboembolism. Despite this long period of scrutiny, pulmonary thromboembolism still remains a life-threatening condition with high morbidity and mortality. A large district general hospital in the UK with a population of 250,000 would expect to treat up to 60 cases of acute pulmonary embolism per year,1 10% of which would be expected to be acute massive pulmonary thromboembolism. This figure is likely to be a conservative estimate as many sudden deaths have only been found to be caused by acute pulmonary embolism at post-mortem examination.2 The 1-year mortality rate in the national multicentre project (PIOPED)3 was reported at approximately 25%, with 2.5% dying from pulmonary embolism itself, and most patients dying from related illnesses. Other studies have reported that in patients without pre-existing cardiac or pulmonary disease, the 1-year mortality rate varied from 3% to 9%.4, 5 If massive pulmonary embolism occurs and is associated with systemic hypotension, the in-hospital mortality is about 18%.6 The persistence of pulmonary hypertension following pulmonary embolism is, in itself, associated with increased mortality with a lower survival rate at 5 years.7 Basic investigations should be performed in all patients both to support the clinical suspicion and to exclude alternative diagnoses. It must be remembered that normal tests do not necessarily exclude the diagnosis of pulmonary thromboembolism, although many publications have produced tables of probability. Basic tests that should be performed in all patients with a suspected pulmonary embolism include chest radiography, electrocardiography and arterial blood gas tensions. Less available but more accurate investigations include ventilation/perfusion isotope scanning, spiral computed tomographic scanning, pulmonary angiography, echocardiography and plasma D-dimers. In the case of acute massive pulmonary thromboembolism, rapid diagnosis is clearly required. Access to investigations leading to the diagnosis are essential and should be performed promptly. Only where there is diagnostic doubt should a more protracted course be allowed. This form of rapid assessment, diagnosis and treatment resembles the fast, slow and no-track system of thrombolysis in acute myocardial infarction. Various therapeutic interventions (pharmacological, interventional and surgical) have been employed since the early 1970s. Despite these various treatment options heparinisation (either fractionated or unfractionated) followed by oral anticoagulation remains the mainstay of treatment. The use of thrombolytic agents (urokinase, streptokinase and recombinant tissue plasminogen activator rt-PA) has been more controversial. The evidence suggests that although there is more rapid resolution of thrombus and haemodynamic improvement in patients treated with a thrombolytic, this does not equate to changes in mortality.12, 13 One argument for this lack of benefit is that patients who have the most to gain frequently die prior to initiation of therapy. Therefore, the influence of thrombolytic agents on the outcome of acute pulmonary thromboembolism remains unclear. Surgical management of patients with pulmonary thromboembolism appears to be better suited to those with chronic symptoms. There have been recent advances in a transvenous approach which has been advocated in acute cases where thrombolysis has either failed or is contraindicated; however, the mortality in these patients still remains very high.14 The use of intracaval filters varies between countries. In the UK such filters seem to be underused; however, data suggest that they have no overall benefit on 2-year mortality. Their use tends to be limited to: patients at high risk of further embolic events; patients unable to take anticoagulation; or those who have had repeat events despite adequate anticoagulation. It is evident that this particular hospital had easy access to pulmonary angiography, although it was only used in one case in order to make the diagnosis. In many hospitals both pulmonary angiography and spiral computed tomography have a similar sensitivity and specificity. They are, however, time consuming and difficult to arrange out of hours and, as a result, can delay treatment. They are also not the best environment in which critically ill patients should be placed if the management of the patient has already been decided. Dr Y Ean Ong and colleagues have followed the British Thoracic Society guidelines16 and used echocardiography which is often more accessible and can be performed easily at the bedside. It has a high sensitivity for massive pulmonary thromboembolism and, in conjunction with the history, allows conformation of the diagnosis facilitating early treatment. Dr Ong and colleagues also illustrate and important point which is easy to forget. Pulmonary thromboembolism is a life-threatening condition and often affects young and old patients alike. It is therefore important that once the diagnosis has been made, advice should be sought from either a senior college or an institution that deals with these cases. Such authorities will be able to advise optimal management including transfer to a cardiothoracic centre should thrombolysis fail or if possible surgical management is contraindicated. It is suggested in the article that the algorithms derived had an impact on the treatment of acute massive pulmonary thromboembolism in the authors' institution. However, additional information would have been helpful in strengthening this point. It would have been interesting to know what delay was encountered when waiting for these investigations and also what effect the algorithms had on the treatment of this condition, compared to management in previous years in the same institution. It is encouraging that district general hospitals are producing detailed guidelines not only for their junior staff but also for their hospital. With the advent of clinical governance it is hoped that national evidence-based guidelines will be produced. At this stage further evaluation of the treatment of acute thromboembolism may become available and the effect of rapid diagnosis and thrombolysis ascertained.
No takes yet. Share an insight, caveat, or question.
Simon A Biggart (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: